An Editorial Archive
News
Editorial dispatches on regulatory, infrastructure and clinical developments shaping Asian regenerative medicine — written at the pace at which news is actually understood, not merely received.
Editorial News
US FDA MFU Developments: 2024-2026 Clearances and Indications
What the FDA actually cleared for Ulthera and Sofwave between 2024 and early 2026, and how the U.S. picture sits next to the Gangnam menu I'm looking at.
Read article →Editorial News
Ultherapy Prime Launch Update: What's Available in Korea Now
The Merz Prime rollout — what landed in Korea when, who adopted it first, and how widely it's actually deployed in Gangnam in 2026.
Read article →Editorial News
Ulthera vs Sofwave Research: What the Comparative Data Says
Reading the published comparative literature with the sponsor disclosure, sample size, and methodology caveats placed where they belong — at the front.
Read article →Editorial News
Ultherapy Prime Clinical Data: What the Studies Actually Say
What's in the Merz published outcomes, the Korean IRB-approved studies, and the patient satisfaction data — read honestly, with the methodology caveats spelled out.
Read article →Editorial News
Ultherapy Pricing in Korea: 2026 Changes Worth Knowing
What shifted between 2024 and 2026 — currency, line-count packaging, the PRIME premium, and the new foreign-patient pricing rules.
Read article →Editorial News
Skin-Tightening Device Recalls: 2024-2026 Safety Updates
How FDA and KFDA recalls, firmware updates, and energy-delivery anomaly bulletins actually work, and what to ask your clinic about the machine before you sign.
Read article →Editorial News
Korean Medical Tourism 2026: KHIDI Numbers Worth Knowing
A Korea-side data dispatch on KHIDI medical tourism stats, US visitor breakdown, Chinese and Japanese share, Gangnam district density, and where the dollars are going.
Read article →Editorial News
Korean Aesthetic Regulatory Update: 2026 Foreign-Patient Rules
What changed in 2026 for English-speaking patients — consent, advertising, refunds, and the KAMI/KHIDI clinic registration framework.
Read article →Editorial News
KFDA MFU Device Updates: New Approvals in Korean Market
What the Ministry of Food and Drug Safety has cleared between 2024 and early 2026, and how the Gangnam consultation menu has shifted as a result.
Read article →Editorial News
AI Face Mapping in Korean Aesthetic Clinics: 2026 Reality Check
Walking into Gangnam consultations in 2026 means walking into AI scanners — here's what the platforms actually do, what the PIPA paper trail says, and what's marketing.
Read article →